SCHEMBL4904210

SCHEMBL4904210

CCN(Sc1ccc(Oc2ccc(OC)cc2)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)OC)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
HSD17B10 Q99714 1/20 0.40
ALDH1A1 P00352 4/20 0.39
TSHR P16473 2/20 0.39
CYP2C9 P11712 4/20 0.39
LMNA P02545 3/20 0.38
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
POLB P06746 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PTGES O14684 1/20 0.36
MMP1 P03956 3/20 0.35
MMP9 P14780 3/20 0.35
MMP13 P45452 3/20 0.35
ADAM17 P78536 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
HTT P42858 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2D6 P10635 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4902983 0.94 ALDH1A1 (0.39) KDM4EHSD17B10ALDH1A1TSHRCYP2C9
SCHEMBL4895549 0.93 ALDH1A1 (0.39) KDM4EHSD17B10ALDH1A1TSHRCYP2C9
SCHEMBL4905600 0.92 ALDH1A1 (0.38) KDM4EHSD17B10ALDH1A1TSHRLMNA
SCHEMBL4902601 0.92 ALDH1A1 (0.38) KDM4EHSD17B10ALDH1A1TSHRCYP2C9
SCHEMBL4905862 0.91 POLB (0.41) LMNAKEAP1NFE2L2POLBPTGES
SCHEMBL4906211 0.90 TSHR (0.41) KDM4EHSD17B10ALDH1A1TSHRCYP2C9
SCHEMBL4899783 0.90 ALDH1A1 (0.40) KDM4EALDH1A1TSHRLMNAPOLB
SCHEMBL4899562 0.89 ALDH1A1 (0.36) ALDH1A1TSHRLMNAMMP9MMP13
SCHEMBL4902777 0.89 PLA2G7 (0.38) KDM4EHSD17B10ALDH1A1TSHRLMNA
SCHEMBL5930735 0.89 TSHR (0.36) KDM4EHSD17B10ALDH1A1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD KDM4E 3750/4885HSD17B10 434/4885ALDH1A1 2664/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD KDM4E 3834/4885HSD17B10 434/4885ALDH1A1 2956/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD KDM4E 3834/4885HSD17B10 434/4885ALDH1A1 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.